214055-12-6

Basic information

• Product Name: (5-chloro-3-fluoropyridin-2-yl)Methanol
• Synonyms: (5-chloro-3-fluoropyridin-2-yl)Methanol
• CAS NO: 214055-12-6
• Molecular Formula: C6H5ClFNO
• Molecular Weight: 161.5614032
• Mol File: 214055-12-6.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (5-chloro-3-fluoropyridin-2-yl)Methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (5-chloro-3-fluoropyridin-2-yl)Methanol(214055-12-6)
• EPA Substance Registry System: (5-chloro-3-fluoropyridin-2-yl)Methanol(214055-12-6)

Safety Data

• Hazardous Substances Data: 214055-12-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(5-chloro-3-fluoropyridin-2-yl)methanol is used as a building block for the synthesis of bioactive molecules, contributing to the development of new pharmaceuticals. Its unique structure and reactivity allow for the creation of diverse compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, (5-chloro-3-fluoropyridin-2-yl)methanol serves as a key intermediate in the production of crop protection products. Its incorporation into these products helps enhance their effectiveness in protecting crops from pests and diseases.
Used in Fine Chemicals Production:
(5-chloro-3-fluoropyridin-2-yl)methanol is utilized as an intermediate in the manufacturing process of fine chemicals. Its unique properties enable the synthesis of high-quality specialty chemicals used in various industries.
Used in Medicinal Chemistry and Drug Discovery:
Due to its distinctive structure, (5-chloro-3-fluoropyridin-2-yl)methanol holds potential in medicinal chemistry and drug discovery. Researchers can leverage its reactivity to design and develop novel compounds with improved pharmacological properties, ultimately contributing to the advancement of healthcare.

Upstream product

• 207994-08-9 5-chloro-3-fluoro-2-pyridinecarboxylic acid 
• 1200498-40-3 methyl 5-chloro-3-fluoropicolinate 

Downstream Products

• 1383924-64-8 5-chloro-2-(chloromethyl)-3-fluoropyridine hydrochloride 
• 214055-11-5 5-chloro-3-fluoropyridine-2-carbaldehyde 
• 1227585-36-5 5-chloro-2-(chloromethyl)-3-fluoropyridine 

Relevant articles and documents

NOVEL IMIDAZOLE COMPOUND AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONIST

The present invention relates to a novel imidazole compound or a pharmaceutically acceptable salt thereof having a melanocortin receptor agonistic activity, and medical use thereof. The present invention relates to an imidazole compound represented by general formula [I] [wherein: Ring A represents an optionally substituted aryl group or the like; R1 represents a hydrogen atom, an optionally substituted alkyl group, or the like; R2 represents a hydrogen atom, a halogen atom, or the like; and R3 represents an optionally substituted alkyl group] or a pharmaceutically acceptable salt thereof.

Pharmaceutical compositions (by machine translation)

[Problem] imidazole compound or its pharmacologically acceptable salt in the melanocortin receptor activity that operates as an active ingredient of a pharmaceutical composition comprising. "I" general formula [a]" Formula, the aryl group may be substituted A ring represents a; R1 Represents a hydrogen atom, or an alkyl group which may be substituted represented; R2 Represents a hydrogen atom, a halogen atom or represents a; R3 The alkyl group may be substituted " represented by the imidazole compound, its pharmacologically acceptable salt as an active ingredient in a pharmaceutical composition. [Drawing] no (by machine translation)

TRICYCLIC PIPERIDINE COMPOUNDS

The present invention relates to compounds of the formula (I) wherein R1a, R1b, R2, R3, (R4)n and ring (A) are as described in the description, to their preparation, to pharmaceutically acc

TRICYCLIC IMIDAZOLE COMPOUNDS AS INHIBITORS OF TRYPTOPHAN HYDROXYLASE

The present invention relates to compounds of the formula (I), wherein R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to thei

TRICYCLIC PIPERIDINE COMPOUNDS

The present invention relates to compounds of the formula (I), wherein R, R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.

FAAH INHIBITORS

The present disclosure relates to compounds useful as inhibitors of the enzyme Fatty Acid Amide Hydrolase (FAAH). The disclosure also provides pharmaceutically acceptable compositions comprising the compounds of the disclosure and methods of using the com